UnitedHealth Group Incorporated (NYSE:UNH) Shares Acquired by Cidel Asset Management Inc.

Cidel Asset Management Inc. raised its holdings in shares of UnitedHealth Group Incorporated (NYSE:UNH) by 4.4% in the second quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The institutional investor owned 4,740 shares of the healthcare conglomerate’s stock after purchasing an additional 200 shares during the quarter. Cidel Asset Management Inc.’s holdings in UnitedHealth Group were worth $2,414,000 at the end of the most recent quarter.

A number of other hedge funds have also recently bought and sold shares of the business. Vanguard Group Inc. grew its stake in UnitedHealth Group by 0.6% during the 1st quarter. Vanguard Group Inc. now owns 84,405,255 shares of the healthcare conglomerate’s stock valued at $41,755,280,000 after purchasing an additional 544,740 shares in the last quarter. Price T Rowe Associates Inc. MD lifted its holdings in UnitedHealth Group by 0.4% during the 1st quarter. Price T Rowe Associates Inc. MD now owns 26,062,928 shares of the healthcare conglomerate’s stock worth $12,893,331,000 after buying an additional 94,641 shares during the last quarter. Capital Research Global Investors lifted its holdings in UnitedHealth Group by 2.2% during the 4th quarter. Capital Research Global Investors now owns 15,122,203 shares of the healthcare conglomerate’s stock worth $7,961,369,000 after buying an additional 324,733 shares during the last quarter. Capital International Investors lifted its holdings in UnitedHealth Group by 4.8% during the 4th quarter. Capital International Investors now owns 11,860,985 shares of the healthcare conglomerate’s stock worth $6,244,158,000 after buying an additional 542,424 shares during the last quarter. Finally, Norges Bank bought a new position in UnitedHealth Group during the 4th quarter worth approximately $5,802,231,000. Institutional investors and hedge funds own 87.86% of the company’s stock.

Insider Activity

In other news, CAO Thomas E. Roos sold 2,851 shares of the company’s stock in a transaction that occurred on Wednesday, July 17th. The stock was sold at an average price of $569.88, for a total value of $1,624,727.88. Following the sale, the chief accounting officer now directly owns 29,501 shares in the company, valued at approximately $16,812,029.88. The transaction was disclosed in a filing with the SEC, which is available at the SEC website. In other UnitedHealth Group news, EVP Erin Mcsweeney sold 1,500 shares of the stock in a transaction on Thursday, July 18th. The stock was sold at an average price of $579.03, for a total value of $868,545.00. Following the transaction, the executive vice president now directly owns 7,785 shares in the company, valued at approximately $4,507,748.55. The sale was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this link. Also, CAO Thomas E. Roos sold 2,851 shares of the firm’s stock in a transaction on Wednesday, July 17th. The stock was sold at an average price of $569.88, for a total value of $1,624,727.88. Following the completion of the transaction, the chief accounting officer now owns 29,501 shares in the company, valued at $16,812,029.88. The disclosure for this sale can be found here. Corporate insiders own 0.33% of the company’s stock.

UnitedHealth Group Stock Performance

Shares of UnitedHealth Group stock traded up $2.96 during trading on Tuesday, reaching $581.74. The company’s stock had a trading volume of 905,880 shares, compared to its average volume of 4,192,560. The company has a debt-to-equity ratio of 0.67, a quick ratio of 0.88 and a current ratio of 0.88. The business’s fifty day moving average price is $531.06 and its 200-day moving average price is $507.93. The firm has a market cap of $537.19 billion, a price-to-earnings ratio of 35.56, a price-to-earnings-growth ratio of 1.61 and a beta of 0.59. UnitedHealth Group Incorporated has a one year low of $436.38 and a one year high of $591.54.

UnitedHealth Group (NYSE:UNH) last issued its quarterly earnings results on Tuesday, July 16th. The healthcare conglomerate reported $6.80 earnings per share (EPS) for the quarter, beating the consensus estimate of $6.66 by $0.14. UnitedHealth Group had a return on equity of 26.55% and a net margin of 3.66%. The firm had revenue of $98.86 billion for the quarter, compared to analyst estimates of $98.73 billion. During the same period in the previous year, the company posted $6.14 earnings per share. The company’s quarterly revenue was up 6.4% compared to the same quarter last year. As a group, equities research analysts predict that UnitedHealth Group Incorporated will post 27.69 earnings per share for the current year.

UnitedHealth Group Dividend Announcement

The company also recently declared a quarterly dividend, which will be paid on Tuesday, September 24th. Investors of record on Monday, September 16th will be paid a dividend of $2.10 per share. The ex-dividend date of this dividend is Monday, September 16th. This represents a $8.40 annualized dividend and a yield of 1.44%. UnitedHealth Group’s dividend payout ratio is 51.34%.

Analyst Upgrades and Downgrades

A number of research firms have commented on UNH. UBS Group increased their target price on UnitedHealth Group from $640.00 to $680.00 and gave the stock a “buy” rating in a report on Thursday, July 18th. Truist Financial raised their price target on UnitedHealth Group from $600.00 to $640.00 and gave the stock a “buy” rating in a report on Wednesday, July 17th. Wells Fargo & Company raised their price target on UnitedHealth Group from $525.00 to $630.00 and gave the stock an “overweight” rating in a report on Wednesday, July 17th. Robert W. Baird raised their price target on UnitedHealth Group from $597.00 to $640.00 and gave the stock an “outperform” rating in a report on Wednesday, July 17th. Finally, Argus raised their price target on UnitedHealth Group from $570.00 to $600.00 and gave the stock a “buy” rating in a report on Wednesday, July 17th. One investment analyst has rated the stock with a hold rating, nineteen have given a buy rating and one has given a strong buy rating to the stock. According to MarketBeat, UnitedHealth Group presently has an average rating of “Buy” and a consensus target price of $614.17.

UnitedHealth Group Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.